Molecular Biology
This research group is dedicated to investigating the genetic and molecular foundations of human diseases, with the goal of identifying biomarkers, elucidating disease mechanisms, and enhancing therapeutic outcomes. The group is actively involved in pharmacogenomics and pharmacogenetics research, examining how genetic variations influence individual drug responses. Their work encompasses a range of critical health conditions, including various cancers, HIV, tuberculosis (TB), psoriasis, autism spectrum disorder, thalassemia, dengue, and COVID-19. Utilizing advanced molecular biology techniques—such as PCR, gene sequencing, and bioinformatics analyses—the team aims to uncover genetic mutations and polymorphisms associated with disease susceptibility and treatment efficacy. Ultimately, this research supports the advancement of personalized medicine in Bangladesh, promoting safer and more effective therapies tailored to individual genetic profiles.INTEREST(S)
-
VISION
The vision of this Research Group is to become an internationally recognized center of excellence in molecular and genetic research, driving innovation in disease prevention, diagnosis, and treatment. Through the integration of advanced molecular tools, interdisciplinary collaboration, and translational research, the group aims to contribute meaningfully to the global advancement of precision medicine—ensuring that every patient receives safe, effective, and personalized healthcare tailored to their genetic profile.
MISSION
The mission of this Research Group is to advance scientific understanding of the genetic and molecular mechanisms underlying human diseases. Through innovative research in molecular biology, pharmacogenomics, and pharmacogenetics, the group strives to identify genetic biomarkers, enhance diagnostic accuracy, and optimize therapeutic strategies. Committed to excellence in research, the team aims to drive the development of personalized medicine and contribute to improved public health outcomes in Bangladesh and beyond.